The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2
- PMID: 9207339
The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2
Abstract
Objective: Neurofibromatosis 1 and neurofibromatosis 2 are autosomal dominant genetic disorders in which affected individuals develop both benign and malignant tumors at an increased frequency. Since the original National Institutes of Health Consensus Development Conference in 1987, there has been significant progress toward a more complete understanding of the molecular bases for neurofibromatosis 1 and neurofibromatosis 2. Our objective was to determine the diagnostic criteria for neurofibromatosis 1 and neurofibromatosis 2, recommendations for the care of patients and their families at diagnosis and during routine follow-up, and the role of DNA diagnostic testing in the evaluation of these disorders.
Data sources: Published reports from 1966 through 1996 obtained by MEDLINE search and studies presented at national and international meetings.
Study selection: All studies were reviewed and analyzed by consensus from multiple authors.
Data extraction: Peer-reviewed published data were critically evaluated by independent extraction by multiple authors.
Data synthesis: The main results of the review were qualitative and were reviewed by neurofibromatosis clinical directors worldwide through an Internet Web site.
Conclusions: On the basis of the information presented in this review, we propose a comprehensive approach to the diagnosis and treatment of individuals with neurofibromatosis 1 and neurofibromatosis 2.
Comment in
-
Physiatry and care of patients with neurofibromatosis.JAMA. 1997 Nov 12;278(18):1493-4. doi: 10.1001/jama.1997.03550180043031. JAMA. 1997. PMID: 9363966 No abstract available.
Similar articles
-
Neurofibromatosis 2.Otolaryngol Clin North Am. 2012 Apr;45(2):315-32, viii. doi: 10.1016/j.otc.2011.12.005. Otolaryngol Clin North Am. 2012. PMID: 22483819 Review.
-
Neurofibromatosis types 1 and 2.Neurologist. 2006 Mar;12(2):86-93. doi: 10.1097/01.nrl.0000195830.22432.a5. Neurologist. 2006. PMID: 16534445 Review.
-
Health supervision for children with neurofibromatosis. American Academy of Pediatrics Committee on Genetics.Pediatrics. 1995 Aug;96(2 Pt 1):368-72. Pediatrics. 1995. PMID: 7630704 No abstract available.
-
[Place of the otorhinolaryngologist in the multidisciplinary approach to neurofibromatosis].Acta Otorhinolaryngol Belg. 1992;46(4):411-20. Acta Otorhinolaryngol Belg. 1992. PMID: 1462783 Dutch.
-
The prenatal diagnosis of NF-1 and NF-2.J Dermatol. 1992 Nov;19(11):885-91. doi: 10.1111/j.1346-8138.1992.tb03800.x. J Dermatol. 1992. PMID: 1293178 No abstract available.
Cited by
-
Drosophila Contributions towards Understanding Neurofibromatosis 1.Cells. 2024 Apr 21;13(8):721. doi: 10.3390/cells13080721. Cells. 2024. PMID: 38667335 Free PMC article. Review.
-
DRI Triton SS-OCT applied to detect choroidal nodules in paediatric patients affected by NF1.Heliyon. 2024 Apr 9;10(8):e29263. doi: 10.1016/j.heliyon.2024.e29263. eCollection 2024 Apr 30. Heliyon. 2024. PMID: 38644819 Free PMC article.
-
Uncommon Thigh Mass in Neurofibromatosis Type 1: Unveiling Aggressive Epithelioid Sarcoma.Eur J Case Rep Intern Med. 2024 Mar 28;11(4):004432. doi: 10.12890/2024_004432. eCollection 2024. Eur J Case Rep Intern Med. 2024. PMID: 38584901 Free PMC article.
-
Craniofacial disorders and dysplasias: Molecular, clinical, and management perspectives.Bone Rep. 2024 Mar 1;20:101747. doi: 10.1016/j.bonr.2024.101747. eCollection 2024 Mar. Bone Rep. 2024. PMID: 38566929 Free PMC article. Review.
-
Neonatal Paratesticular Scrotal Mass: A Rare Case of Atypical Neurofibromatous Neoplasm with Uncertain Biologic Potential.Afr J Paediatr Surg. 2024 Apr 1;21(2):148-150. doi: 10.4103/ajps.ajps_17_23. Epub 2023 Jul 20. Afr J Paediatr Surg. 2024. PMID: 38546256 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials